Cetylpyridinium

Cetylpyridinium

SCHEMBL666197

CCCCCCCCCCCCCCCC[n+]1ccccc1.O=C(Oc1ccccc1C(=O)[O-])c1ccccc1O

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.49
HPGD P15428 2/20 0.49
HSD17B10 Q99714 2/20 0.49
ALDH1A1 P00352 1/20 0.49
CHRM2 P08172 3/20 0.43
ADRA2A P08913 3/20 0.43
SLC6A3 Q01959 3/20 0.43
ADORA3 P0DMS8 2/20 0.43
CHRM1 P11229 2/20 0.43
ACHE P22303 2/20 0.43
SLC6A2 P23975 2/20 0.43
SLC6A4 P31645 2/20 0.43
ABCB11 O95342 1/20 0.43
ESR1 P03372 1/20 0.43
PGR P06401 1/20 0.43
HTR1A P08908 1/20 0.43
DRD1 P21728 1/20 0.43
TBXA2R P21731 1/20 0.43
PTGS1 P23219 1/20 0.43
PDE4A P27815 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cetylpyridinium SCHEMBL667616 0.87 CHRM2 (0.54) KDM4EHPGDALDH1A1CHRM2ADRA2A
Cetylpyridinium SCHEMBL666198 0.84 CHRM2 (0.50) KDM4EHPGDALDH1A1CHRM2ADRA2A
Salsalate SCHEMBL11218871 0.82 KDM4E (0.52) KDM4EHPGDHSD17B10ALDH1A1CHRM2
Cetylpyridinium SCHEMBL2369768 0.80 KMT2A (0.43) KDM4EHPGDHSD17B10ALDH1A1CHRM2
Cetylpyridinium SCHEMBL28035036 0.80 CHRM2 (0.57) KDM4EHPGDALDH1A1CHRM2ADRA2A
Salsalate SCHEMBL668243 0.79 KDM4E (0.52) KDM4EHPGDHSD17B10ALDH1A1CHRM2
Salsalate SCHEMBL668410 0.78 KDM4E (0.51) KDM4EHPGDHSD17B10ALDH1A1CHRM2
Cetylpyridinium SCHEMBL2369770 0.77 MAPT (0.43) KDM4ECHRM2ADRA2ASLC6A3ADORA3
Salsalate SCHEMBL4090721 0.77 HSD17B10 (0.70) KDM4EHPGDHSD17B10ALDH1A1SLC6A3
Salsalate SCHEMBL18889812 0.77 HSD17B10 (0.70) KDM4EHPGDHSD17B10ALDH1A1SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9278134-B2 Dual functioning ionic liquids and salts thereof THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2016-03-08 US disclosed
US-20130203602-A1 SUPPORTED BIOLOGICALLY ACTIVE COMPOUNDS DANMARKS TEKNISKE UNIVERSITET (DK) 2013-08-08 US disclosed
EP-2544664-A1 SUPPORTED BIOLOGICALLY ACTIVE COMPOUNDS Danmarks Tekniske Universitet (DK) 2013-01-16 EP disclosed
US-20120046244-A1 DUAL FUNCTIONING IONIC LIQUIDS AND SALTS THEREOF THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2012-02-23 US disclosed
WO-2011110662-A1 SUPPORTED BIOLOGICALLY ACTIVE COMPOUNDS DANMARKS TEKNISKE UNIVERSITET (DK) 2011-09-15 WO disclosed
WO-2010078300-A1 DUAL FUNCTIONING IONIC LIQUIDS AND SALTS THEREOF THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130203602-A1 SUPPORTED BIOLOGICALLY ACTIVE COMPOUNDS MIF, BMP2, BMP4 KDM4E 3887/4885HPGD 1255/4885HSD17B10 2196/4885
US-20120046244-A1 DUAL FUNCTIONING IONIC LIQUIDS AND SALTS THEREOF SLC6A6, SLC10A2, CLK2 KDM4E 4730/4885HPGD 1301/4885HSD17B10 1894/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.